Viewing Study NCT00949351


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2025-12-25 @ 9:47 PM
Study NCT ID: NCT00949351
Status: UNKNOWN
Last Update Posted: 2009-07-30
First Post: 2009-07-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy
Sponsor: Lerdsin General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module